Skip to content

Body & Abdominal Imaging

Hepatobiliary, genitourinary, pancreatic and solid-organ tools.

Adrenal MRI Chemical Shift (Signal Intensity Index & Adrenal-to-Spleen Ratio)
Chemical-shift quantitative criteria (RadioGraphics 2016)

Quantifies signal drop of an adrenal lesion from in-phase to opposed-phase gradient-echo MRI. Values above validated thresholds indicate intracellular lipid and support a lipid-rich adenoma.

Adrenal Washout Calculator (CT)
Adrenal CT washout criteria (Caoili 2002 / Szolar 1998)

Computes absolute and relative percentage washout of an adrenal nodule on multiphase CT. Adenomas typically enhance briskly and wash out rapidly, meeting the 60% absolute or 40% relative washout thresholds.

Pancreatic Collections Nomenclature & Modified CT Severity Index
Revised Atlanta (2012) + Modified CTSI (Mortele 2004)

Names pancreatic and peripancreatic collections correctly per the Revised Atlanta Classification and scores radiologic severity of acute pancreatitis with the Modified CT Severity Index (Mortele).

Thyroid Volume Calculator (Ultrasound)
Ellipsoid / Brunn-WHO volumetry (Brunn 1981)

Estimates total thyroid volume from three orthogonal measurements of each lobe using the standard ellipsoid formula or the Brunn (WHO) correction factor.

ACR TI-RADS (Thyroid Nodule Risk Stratification)
ACR TI-RADS (2017)

Scores a thyroid nodule from five ultrasound feature categories and maps the total to ACR TI-RADS levels TR1-TR5 with size-based FNA and follow-up recommendations.

C-RADS v2023 (CT Colonography Reporting & Data System)
C-RADS v2023

Assigns colonic (C0-C4) and extracolonic (E0-E4) categories for CT colonography per the ACR C-RADS 2023 update, with the corresponding management recommendations.

Bladder Volume Calculator (Ultrasound)
Bih shape-specific coefficients (1998)

Estimates urinary bladder volume from three orthogonal ultrasound dimensions using a shape-dependent correction coefficient, with an approximate error range from the original validation study.

Bosniak Classification v2019 (Cystic Renal Mass, CT/MRI)
Bosniak v2019

Classifies cystic renal masses into Bosniak classes I through IV using the 2019 revised criteria for CT and MRI, and identifies lesions to which the system does not apply.

Testicular & Ovarian Volume Calculator
Ellipsoid 0.523 (ovary) / Lambert 0.71 (testis)

Estimates ovarian or testicular volume from three orthogonal measurements. The ovary uses the standard ellipsoid constant (0.523); the testis uses the Lambert constant (0.71), which best matches true volume by water displacement.

PI-RADS v2.1 (Prostate MRI)
ACR PI-RADS v2.1 (2019)

Assigns an ACR PI-RADS v2.1 assessment category (1-5) to a prostatic lesion on multiparametric MRI, using zone-specific dominant sequences: DWI for the peripheral zone and T2W for the transition zone, with DCE as a tie-breaker in the peripheral zone.

Prostate Volume & PSA Density
Ellipsoid/bullet volume formulas; PSAD threshold 0.15 ng/mL2

Estimates prostate volume from three orthogonal dimensions using the ellipsoid (or bullet) formula and computes PSA density (serum PSA divided by gland volume), a risk marker used when interpreting PSA and MRI findings.

RENAL Nephrometry Score
RENAL nephrometry (Kutikov & Uzzo 2009)

Standardized anatomic complexity score (Kutikov & Uzzo 2009) for solid renal masses, summing radius, exophytic/endophytic growth, nearness to the collecting system, anterior/posterior location, and polar-line relationship, with an "h" suffix for hilar contact.

Acute Cholecystitis Risk (Ultrasound + Clinical)
Patel et al. 2026 risk algorithm (with TG18/WSES context)

Risk-stratifies the probability of acute cholecystitis on gallbladder ultrasound using the data-derived algorithm of Patel et al. (2026): gallbladder distention, wall, contents, pericholecystic collections, hepatic artery PSV, sonographic Murphy sign, demographics and WBC are combined into practically excluded / reduced / elevated / substantially elevated risk, with approximate probability bands.

LI-RADS v2018 (CT/MRI)
ACR LI-RADS v2018

Categorizes liver observations in at-risk patients per ACR LI-RADS v2018: untreated observations are assigned LR-NC/1/2/3/4/5/M/TIV from major features (nonrim APHE, size, enhancing capsule, nonperipheral washout, threshold growth) with optional ancillary-feature adjustment; treated observations receive a treatment response (LR-TR) category.

Hepatic Steatosis (CT & MRI)
CT HU criteria (40 HU / 10 HU / 20 HU) + chemical-shift MRI dropout

Assesses diffuse hepatic steatosis: on non-contrast CT via absolute liver attenuation (<40 HU) and spleen-minus-liver difference (>10 HU), on contrast CT via a >20 HU spleen-liver difference, and on chemical-shift MRI via signal dropout and estimated fat fraction from in-/out-of-phase liver (and spleen) signal.

Liver Volume (CT/MRI/US) + Expected Volume
Muggli 0.31 (CT/MRI); Childs US formula; Heinemann & Vauthey expected volumes

Estimates liver volume from cross-sectional dimensions (0.31 x L x W x H on CT/MRI per Muggli et al.; three-measurement ultrasound formula of Childs et al.) and computes expected standard liver volume from body weight (Heinemann) and from BSA (Vauthey), useful before hepatectomy and for hepatomegaly assessment.

Spleen Volume & Splenic Index
Splenic index (120-480 cm3); ellipsoid 0.524; Chow 2016 limits

Computes the splenic index (L x W x thickness, normal ~120-480 cm3), ellipsoid splenic volume (0.524 x L x W x T), and a revised ultrasound volume averaging maximal and craniocaudal length; optional height-based upper normal limits contextualize splenomegaly.

Solid Organ Volume (Ellipsoid)
Prolate ellipsoid (pi/6 ~ 0.524)

Generic solid-organ volume from three orthogonal dimensions using the prolate ellipsoid formula (L x W x H x pi/6), applicable on CT, MRI or ultrasound to organs and focal masses such as kidneys, pancreas, lymph nodes and thyroid lobes.

Child-Pugh Score (Child-Turcotte-Pugh)
Child-Pugh (Pugh modification, 1973)

Grades chronic liver disease severity from bilirubin, albumin, INR, ascites and encephalopathy into classes A (5-6), B (7-9) and C (10-15). The class feeds prognostic estimates and treatment algorithms such as BCLC and TACE selection.

ALBI (Albumin-Bilirubin) Grade
ALBI (Johnson 2015)

Objective liver-function grading from serum albumin and total bilirubin alone. ALBI = 0.66 x log10(bilirubin in umol/L) - 0.085 x albumin (g/L), banded into grades 1-3 that stratify prognosis and therapy selection in HCC.

FIB-4 (Fibrosis-4) Index
FIB-4 (Sterling 2006; MASLD cutoffs Shah 2009)

Estimates liver fibrosis risk from age, AST, ALT and platelet count. Originally derived in HIV/HCV coinfection and now the guideline first-line screen for advanced fibrosis in MASLD; both validated cutoff conventions are reported and labeled.

APRI (AST-to-Platelet Ratio Index)
APRI (Wai 2003; WHO thresholds)

Simple fibrosis marker computed as (AST / AST upper limit of normal) x 100 / platelets. WHO-endorsed when elastography or biopsy is unavailable; labeled bands flag significant fibrosis (0.5/1.5) and cirrhosis (1.0/2.0).

BCLC Staging & Treatment Strategy (2022 Update)
BCLC 2022 (Reig et al.)

Assigns Barcelona Clinic Liver Cancer stage 0/A/B/C/D from tumor burden, cancer-related performance status and liver function, and returns the evidence-based first-line treatment strategy of the 2022 update.

Clear Cell Likelihood Score (ccLS) v2.0 — Renal Mass mpMRI
ccLS v2.0 (Pedrosa & Cadeddu 2022)

Five-tier MRI score (1-5) estimating the likelihood that an indeterminate solid renal mass is clear cell RCC, from T2 signal, corticomedullary enhancement, microscopic fat and ancillary features (DWI, segmental enhancement inversion, ADER).

Ranson Criteria for Acute Pancreatitis Severity
Ranson 1974 (classic non-gallstone criteria)

Scores 5 admission and 6 forty-eight-hour clinical criteria in acute pancreatitis; a total of 3 or more predicts severe disease, with rising mortality bands at 3-5 and 6 or more criteria.

VI-RADS (Bladder Cancer Muscle Invasion, mpMRI)
VI-RADS (Panebianco 2018)

Combines the T2W structural category, DWI category, and DCE category (each 1–5) of a bladder tumor on mpMRI into the overall VI-RADS score, with the associated probability band for detrusor muscle invasion and staging guidance.

SRU Gallbladder Polyp Follow-up (2022 Consensus)
SRU Consensus Conference Recommendations (Kamaya 2022)

Applies the Society of Radiologists in Ultrasound 2022 consensus for incidentally detected gallbladder polyps: morphology first (extremely low, low, or indeterminate risk), then size, returning no-follow-up, surveillance ultrasound intervals, or surgical consultation.

Milan Criteria / UCSF (Expanded) Criteria
Milan 1996; UCSF 2001

Determines whether hepatocellular carcinoma burden meets the classic Milan criteria and the more permissive UCSF expanded criteria for liver transplant candidacy, using tumor number, lesion diameters, and presence of macrovascular invasion or extrahepatic disease.

EU-TIRADS / ATA / Kwak-TIRADS
EU-TIRADS 2017; ATA 2015; Kwak TIRADS 2011

Single form that applies European EU-TIRADS, American Thyroid Association 2015 sonographic patterns, or Kwak TIRADS to the same ultrasound feature set and returns the risk category plus size-based FNA threshold for the selected system.

RMI (Risk of Malignancy Index)
RMI 1 (Jacobs 1990); threshold 200

Calculates the Risk of Malignancy Index for an adnexal mass from ultrasound feature count (U), menopausal status (M), and serum CA-125, flagging scores above 200 as high risk warranting gynae-oncology referral.

ADNEX Model (IOTA)
IOTA ADNEX (Van Calster BMJ 2014; Evidencio formula v2)

Implements the IOTA ADNEX multinomial logistic model to estimate probabilities that an adnexal mass is benign, borderline, stage I primary invasive, stage II–IV primary invasive, or metastatic, using age, optional CA-125, and six ultrasound predictors.

AAST Pancreas Injury Scale
AAST pancreas OIS (Moore 1990; widely cited 2018 trauma practice)

Assigns AAST grade I–V for traumatic pancreatic injury based on contusion versus laceration, presence of duct injury, and whether the injury is distal, proximal (ampullary), or a massive head disruption.

AAST Adrenal Injury Scale
AAST adrenal OIS (Moore et al.)

Grades traumatic adrenal injury from cortical contusion (I) through deep medullary laceration and extensive parenchymal destruction to avulsion from the blood supply (V).

AAST Bladder Injury Scale
AAST bladder OIS (Moore et al.)

Grades bladder trauma from contusion or partial-thickness injury through sized extra- and intraperitoneal ruptures to injuries involving the trigone or bladder neck.

AAST Bowel and Mesenteric Injury Scale
AAST small bowel / colon OIS (Moore 1990) — combined bowel–mesentery presentation

Selects AAST grade I–V for bowel wall and mesenteric trauma, from hematoma or partial-thickness injury without devascularization through full-thickness laceration, transection, and segmental devascularization.

AAST Diaphragm Injury Scale
AAST diaphragm OIS (Moore 1994)

Grades diaphragmatic injury from contusion through lacerations sized ≤2 cm, 2–10 cm, and >10 cm with limited tissue loss, up to large tissue loss >25 cm².

AAST Duodenum Injury Scale
AAST duodenum OIS (Moore 1990)

Grades duodenal trauma from intramural hematoma of a single portion through circumferential disruption, ampullary involvement, and massive pancreaticoduodenal destruction or devascularization.

AAST Urethra Injury Scale
AAST urethra OIS (Moore et al.)

Grades urethral trauma from contusion and stretch injury through partial and complete disruption, including complete transection with wide separation or extension into prostate or vagina.